Guiding Startup Triumph: The Vital Role of Independent Advisors and Platforms in Achieving Success

I'm excited to share my professional journey and expertise in branding, marketing, and strategic communication. After more than 37 rewarding years working across diverse industries and academic roles, I continue to seek ways to empower others through creative and strategic insights. To learn more about my experience and passion for shaping meaningful communications and strategies, here is my biography.

After 20+ years in marketing, media, and advertising, I’m excited to share my professional biography. It highlights my journey from local media sales to leading omni-channel strategy for national clients, and my continued passion for growth, insight, and impact. Here is my biography.

Dr. Stephen M. Chang is a distinguished human geneticist with over 32 years of commercial experience in the life sciences, specializing in stem cells, cell and gene therapy, and drug development. He has co-founded multiple companies, including Orpheus Therapeutics, Legacy Therapeutics, Prometheus Therapeutics, and Princeton Drug Discovery, and serves on the boards of Orpheus Therapeutics and Histogen, Inc., where he is also Chairman and Acting CEO. Dr. Chang has held significant roles such as Vice President for Research & Development and Senior Vice President for Strategic Initiatives at the New York Stem Cell Foundation, and Chief Science Officer and Vice President at Canji Inc./Schering Plough Research Institute. His academic background includes a Ph.D. in Biological Chemistry from the University of California, Irvine, and a B.S. in Zoology, Microbiology, and Cell and Molecular Biology from the University of Michigan. Throughout his career, Dr. Chang has co-authored over 30 published papers, filed more than 15 Investigational New Drug Applications with the FDA, and is an inventor on over 50 patents worldwide. He is recognized as a pioneer in commercial gene therapy technologies and induced pluripotent stem cells, with recent successful drug developments including Adstilirin™ (rAd-IFN/Syn3) for bladder cancer therapy and Intravail™ diazepam for epilepsy treatment. Dr. Chang also serves as Entrepreneur in Residence at Rutgers University and New York University, providing strategic guidance on genetic technologies and their market applications.

Excited to share my journey of over 38 years in media and communications. From working with major news outlets like ABC News and CNN to leading media relations and corporate branding for healthcare, pharma, and biotech clients at Russo Partners, it’s been a privilege to help tell impactful stories across industries. I’m passionate about guiding businesses in navigating the evolving media landscape and ensuring their message reaches the right audience. Feel free to read my full bio to learn more about my experience and what drives my work!

I'm thrilled to share my journey as a media-minded marketing and communications expert. With over 40 years in the industry, I've had the privilege of driving growth for brands across diverse sectors. From founding SOS Media Group to leading Kensington Hill Media, my expertise in strategic marketing, digital strategy, and creative leadership has empowered numerous businesses to achieve their goals. I'm passionate about leveraging my experience and innovative approach to transform marketing strategies and elevate brands. Discover more about my journey and achievements in my latest executive biography.